Biotech Investissement - 02/10/2012

 

Biotech Investissement (France) acquires Diaclone SAS

 


We are delighted to announce that on October 2, 2012, the acquisition of Diaclone SAS (Besançon, France) was completed by the French based group Biotech Investissement who also own RD-Biotech SAS (Besançon, France) a respected Contract Research Organisation.

 

Diaclone SAS remains committed to serving the business needs of our customers. We expect the acquisition to bring greater opportunity for us to work closer together with all our customers and partners as we strive to continue to provide the same high quality products and service on which Diaclone have built a reputation for over 25 years.

 

Please contact us for further information

info@diaclone.com

 


< Back to latest news